Small tumor size and node-negative HER2-positive breast cancer: a step forward for a better treatment?
Crivellari
Diana
D
Molino
Annamaria
A
D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D015412:Mastectomy, Segmental / Q000379:methods; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*; D018570:Risk Assessment; D016019:Survival Analysis; D013997:Time Factors; D047368:Tumor Burden
D018719:Erb-b2 Receptor Tyrosine Kinases